Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how tumors in patients with colorectal carcinoma
respond to treatment with VELCADE alone versus VELCADE given with irinotecan, and also to see
what effects (good and bad) it has on you and your cancer.